Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Cardiol Therapeutics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 29 | 28 | −1 |
| Shares | 6.35M | 6.24M | −104.3K (−1.6%) |
| Value | $10.1M | $8.58M | −$1.55M (−15.3%) |
New holders (6)
Institutions that held Cardiol Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of America Corp | 19,113 | $25.0K | 0.00% |
| Brookstone Capital Management | 15,025 | $20.0K | 0.00% |
| LPL Financial LLC | 10,230 | $14.0K | 0.00% |
| We Are One Seven, LLC | 10,000 | $13.0K | 0.00% |
| Citigroup Inc | 792 | $1.00K | 0.00% |
| BlackRock Inc. | 40 | $0 | 0.00% |
Sold out (7)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Goldman Sachs Group Inc | 65,600 | $100.0K |
| Jane Street Group, LLC | 36,576 | $57.0K |
| Belvedere Trading LLC | 16,010 | $29.0K |
| CIBC World Markets Inc. | 11,210 | $17.0K |
| Bank of Montreal | 8,731 | $13.0K |
| Commons Capital, LLC | 2,500 | $4.00K |
| Northwestern Mutual Wealth Management Co | 25 | $0 |